2011
DOI: 10.1007/s13337-011-0032-5
|View full text |Cite
|
Sign up to set email alerts
|

Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle

Abstract: DNA vaccines are considered as alternatives to live attenuated ones for those diseases like foot-and-mouth disease (FMD) where the production and application of live vaccines have been found unsuccessful. However, stability of DNA and the quantity of antigen expressed are the major limitation with naked DNA vaccines. To address these issues self replicating gene vaccine construct was made for foot-and-mouth disease virus (FMDV) type 'O' and studied. The vector for vaccine construct, designated as pSinCMVVac ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…The CMI responses against antigen stimulation were assessed by PBMC proliferation by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide ( MTT ) assay ( Nagarajan et al, 2011 ). The PBMCs were separated by Histopaque 1077 (Sigma, St. Louis, MO) density gradient centrifugation.…”
Section: Methodsmentioning
confidence: 99%
“…The CMI responses against antigen stimulation were assessed by PBMC proliferation by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide ( MTT ) assay ( Nagarajan et al, 2011 ). The PBMCs were separated by Histopaque 1077 (Sigma, St. Louis, MO) density gradient centrifugation.…”
Section: Methodsmentioning
confidence: 99%
“…Sindbis virus replicase‐based vector pSinCMV‐Vac [33] was used for constructing the replicase‐based DNA vaccine for FMD. The plasmid pET‐MEG990 [34] was used as a source of the FMDV‐specific multivalent epitope gene (MEG990).…”
mentioning
confidence: 99%
“…Construction of the replicase‐based DNA vaccine encoding FMDV multiple epitopes, pSinCMV‐Vac‐MEG990. Construction of the SINV replicase‐based vector, pSinCMV‐Vac [33], and the linking of C‐terminal halves of VP1 of serotype O, A and Asia 1 by viral 2A sequences into MEG990 gene were described earlier [34]. In the present study, the FMDV‐specific MEG990 gene was inserted into the pSinCMV‐Vac for use as a DNA vaccine for FMD.…”
mentioning
confidence: 99%